Form D · Pharmaceuticals
VILLYA LLC
Melbourne, FL · CIK 0002004852
Offering snapshot reported Dec 18, 2023 · SEC filing
- Reported sold
- $250K Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 8, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 18, 2023 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-499999
Right to acquire another security - SAFE
Source: Form D, filed Dec 18, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Miller | Director, Executive, Promoter |
| Diana Miller | Executive |
| Ron Ray | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6300 N. Wickham Road Suite 130 #194
Melbourne, FL, 32940
Melbourne, FL, 32940